Taiko Pharmaceutical Co (TSE:4574) Other Current Liabilities : 円338 Mil (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Taiko Pharmaceutical Co Other Current Liabilities?

Taiko Pharmaceutical Co's other current liabilities for the quarter that ended in Mar. 2024 was 円338 Mil.

Taiko Pharmaceutical Co's quarterly other current liabilities declined from Sep. 2023 (円761 Mil) to Dec. 2023 (円656 Mil) and declined from Dec. 2023 (円656 Mil) to Mar. 2024 (円338 Mil).

Taiko Pharmaceutical Co's annual other current liabilities increased from Mar. 2020 (円1,683 Mil) to Dec. 2021 (円1,770 Mil) but then declined from Dec. 2021 (円1,770 Mil) to Dec. 2022 (円880 Mil).

Taiko Pharmaceutical Co Other Current Liabilities Historical Data

The historical data trend for Taiko Pharmaceutical Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiko Pharmaceutical Co Other Current Liabilities Chart

Taiko Pharmaceutical Co Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Dec21

Dec22

Other Current Liabilities

Get a 7-Day Free Trial

Taiko Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Taiko Pharmaceutical Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Taiko Pharmaceutical Co Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Taiko Pharmaceutical Co's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiko Pharmaceutical Co (TSE:4574) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taiko Pharmaceutical Co Ltd (TSE:4574) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 34 Third Street, No. 14, Uchihon Suita, Osaka, JPN, 564-0032

Website

http://www.seirogan.co.jp

Taiko Pharmaceutical Co Ltd operates in three segments, namely Pharmaceutical, Infection Control, and Others. The majority of its revenue comes from Infection Control, which is into manufacturing and sales of sanitation control products, including Cleverin, Cleverin LED, and Cleverin Generator LISPASS. The pharmaceutical segment is into the manufacturing and sales of OTC medicines and designated quasi-drugs. Other business includes manufacturing and sales of wood vinegar-based products.

Taiko Pharmaceutical Co (TSE:4574) Headlines

No Headlines